Drug intelligence / Profile preview

RU78783

Development stage: Unknown
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules

Overview

RU78783 is an experimental small molecule belonging to the class of bisphosphonates, which are organic compounds containing two phosphonate groups. It has a chemical formula of C7H10O6P2 and a molecular weight of approximately 252.1 g/mol. The compound is not approved for clinical use in any country and has not advanced beyond preclinical or early research stages, with no reported indications or clinical trials in humans. Its mechanism of action and potential therapeutic applications remain uncharacterized in publicly available sources[1][3][2].

Other names: DB02908DB-02908DB 02908

Targets

FDPS (Farnesyl pyrophosphate synthase)

Beyond the preview

Go deeper on RU78783.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RU78783.

Explore the full profile